FIELD: medicine.
SUBSTANCE: invention relates to field of medicine and pharmaceutics and concerns combined anti-tuberculosis composition in form of solid medicinal form including as active components riphampicin, levofloxacin, isoniazide, pyrazinamide and pyridoxine hydrochloride.
EFFECT: increased treatment efficiency.
8 cl, 1 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL ANTI-TUBERCULOSIS COMBINED COMPOSITION | 2011 |
|
RU2478389C2 |
COMPOSITE PHARMACEUTICAL COMPOSITION WITH ANTITUBERCULOUS ACTIVITY | 2003 |
|
RU2247561C1 |
COMPOSITE FORMULATION WITH ANTITUBERCULOUS ACTIVITY | 2003 |
|
RU2247560C1 |
ANTITUBERCULOUS AGENT | 2003 |
|
RU2247559C1 |
COMBINED ANTITUBERCULOUS DRUG AND METHOD FOR PREPARING THEREOF | 2008 |
|
RU2431487C2 |
COFORMULATED ANTITUBERCULOUS DRUG | 2009 |
|
RU2430724C2 |
COMBINED ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION | 2009 |
|
RU2422145C2 |
COMBINED ANTITUBERCULAR PREPARATION AND METHOD FOR ITS OBTAINING | 2001 |
|
RU2182483C1 |
COMBINED ANTITUBERCULOUS COMPOSITION | 2009 |
|
RU2413517C1 |
COMBINED ANTITUBERCULOUS COMPOSITION | 2010 |
|
RU2468802C2 |
Authors
Dates
2009-05-10—Published
2007-07-09—Filed